Oncternal TherapeuticsONCT
13F holders, Q4 2025 (December 31)2holders +1
1new positions
0sold out
$0.47avg. 13F price*
At the end of Q4 2025, 2 institutions reported holding Oncternal Therapeutics Inc. (ONCT) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 0 sold out. The largest holders were BNP Paribas Financial Markets ($96) and Union Bancaire Privee, UBP SA ($73).
- Company
- Oncternal Therapeutics Inc.
- CUSIP
- 68236P206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $96 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q4 2025: 182 shares bought, net +182 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| BNP Paribas Financial Markets | 0.00% | New | 182 | $96 |
| Union Bancaire Privee, UBP SA | 0.00% | No change | 175 | $73 |
"% of holder's portfolio" is ONCT's weight in each manager's 13F, not the share of Oncternal Therapeutics Inc. the manager owns.